| 000 | 05692nam a22006375i 4500 | ||
|---|---|---|---|
| 001 | 978-1-0716-3346-5 | ||
| 003 | DE-He213 | ||
| 005 | 20260610083647.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 230714s2023 xxu| s |||| 0|eng d | ||
| 020 |
_a9781071633465 _9978-1-0716-3346-5 |
||
| 024 | 7 |
_a10.1007/978-1-0716-3346-5 _2doi |
|
| 050 | 4 | _aRC261-271 | |
| 072 | 7 |
_aMJCL _2bicssc |
|
| 072 | 7 |
_aMED062000 _2bisacsh |
|
| 072 | 7 |
_aMJCL _2thema |
|
| 082 | 0 | 4 |
_a571.978 _223 |
| 082 | 0 | 4 |
_a616.994 _223 |
| 245 | 1 | 0 |
_aLiquid Biopsies _h[electronic resource] : _bMethods and Protocols / _cedited by Tao Huang, Jialiang Yang, Geng Tian. |
| 250 | _a1st ed. 2023. | ||
| 264 | 1 |
_aNew York, NY : _bSpringer US : _bImprint: Humana, _c2023. |
|
| 300 |
_aXIII, 368 p. 1 illus. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 341 | 0 |
_bTable of contents navigation _2onix |
|
| 341 | 0 |
_bSingle logical reading order _2onix |
|
| 341 | 0 |
_bShort alternative textual descriptions _2onix |
|
| 341 | 0 |
_bUse of color is not sole means of conveying information _2onix |
|
| 341 | 0 |
_bUse of high contrast between text and background color _2onix |
|
| 341 | 0 |
_bNext / Previous structural navigation _2onix |
|
| 341 | 0 |
_bAll non-decorative content supports reading without sight _2onix |
|
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aMethods in Molecular Biology, _x1940-6029 ; _v2695 |
|
| 505 | 0 | _aThe Protocol of Circulating Tumor Cell Detection -- Cell-free RNA sequencing from biofluid samples -- Detection of Circulating Tumor DNA in plasma using Targeted Sequencing -- Exosomal RNA sequencing from body fluid samples -- Detection of micro-organisms in body fluid samples -- The Interactome of Protein, DNA and RNA -- Liquid biopsy in bladder cancer -- CSF Biopsy in Glioma: ABrief Review -- Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy -- The implication of liquid biopsy in the non-small cell lung cancer: potential and expectation -- Cell-free DNA, MicroRNAs, Proteins and Peptides as liquid biopsy biomarkers in prostate cancer and bladder cancer.-Identification of plasma metabolites associated with lung cancer survival -- The detection of exosomal PD-L1 in peripheral blood -- Liquid Biopsy in Hepatocellular Carcinoma -- Role of circulating tumor DNA in colorectal cancer -- The value of cell-free circulating DNA profiling in patients with skin diseases -- The value of cell-free circulating DNA profiling in patients with skin diseases -- Circulating non-coding RNAs and exosomes: liquid biopsies for monitoring preeclampsia -- Liquid Biopsy in Coronary Heart Disease -- The diagnostic and prognostic value of synovial fluid analysis in joint diseases -- Liquid biopsy, a potential new detection method in heart allograft rejection -- Potential value and application of liquid biopsy in tumor, neurodegeneration and muscle degenerative diseases -- Liquid biopsy in adverse neurodevelopment of children: problems and prospects -- Advances of liquid biopsy for diagnosis of atrial fibrillation and its recurrence after ablation in clinical application. . | |
| 520 | _aThis book analyzes liquid biopsy applications in cancer and other diseases. Chapters guide readers through the latest technologies and analysis methods for liquid biopsy,liquid biopsy in cancer, role of liquid biopsies in rheumatoid arthriti, cell-free circulating DNA profiling in patients with skin diseases, circulating non-coding RNAs, and exomes. Written in the format of the highly successful Methods in Molecular Biology series, each chapter includes an introduction to the topic, lists necessary materials and reagents, includes tips on troubleshooting and known pitfalls, and step-by-step, readily reproducible protocols. Authoritative and cutting-edge, Liquid Biopsies: Methods and Protocols aims to attract more researchers and clinicians to study the diagnosis, immunotherapy, and prognosis of cancer and other diseases with liquid biopsy analysis. | ||
| 532 | 8 | _aAccessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | _aNo reading system accessibility options actively disabled | |
| 532 | 8 | _aPublisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 650 | 0 | _aCancer. | |
| 650 | 0 | _aGenetics. | |
| 650 | 1 | 4 | _aCancers. |
| 650 | 2 | 4 | _aGenetics and Genomics. |
| 700 | 1 |
_aHuang, Tao. _eeditor. _0(orcid)0000-0003-1975-9693 _1https://orcid.org/0000-0003-1975-9693 _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aYang, Jialiang. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aTian, Geng. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071633458 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071633472 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071633489 |
| 830 | 0 |
_aMethods in Molecular Biology, _x1940-6029 ; _v2695 |
|
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-1-0716-3346-5 |
| 912 | _aZDB-2-PRO | ||
| 999 |
_c6464 _d6464 |
||